Übersichtsarbeiten - OUP 05/2015

Intraartikuläre Therapie der Arthrose

12 Yamamoto T, Schneider R, Iwamoto Y et al. Rapid destruction of the femoral head after a single intraarticular injection of corticosteroid into the hip joint. J. Rheumatol. 2006; 33, no. 8: 1701–4

13 Cheng OT, Souzdalnitski D, Vrooman B et al. Evidence-based knee injections for the management of arthritis.,” Pain Med. 2012; 13, no. 6: 740–53

14 Lehmann L, Stöve J. Pain symptoms of osteoarthritis-aspects of etiology and therapy. Schmerz 2004; 18, no. 6: 453–62

15 Bellamy N, Campbell J, Robinson V et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane database Syst. Rev. 2006, no. 2, p. CD005321

16 Chu CR, Izzo NJ, Coyle CH et al. The in vitro effects of bupivacaine on articular chondrocytes. J. Bone Joint Surg. Br. 2008; 90, no. 6: 814–20a

17 Band PA, Heeter J, Wisniewski HG et al. Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression. Osteoarthritis Cartilage 2014

18 Reichenbach S, Blank S, Rutjes AWS et al. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum. 2007; 57, no. 8: 1410–8

19 Stöve J, Gerlach C, Huch K et al. Effects of hyaluronan on proteoglycan content of osteoarthritic chondrocytes in vitro. J. Orthop. Res. 2002; 20, no. 3: 551–5

20 Pozo MA, Balazs EA, Belmonte C. Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp. brain Res. 1997; 116, no. 1: 3–9

21 Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res. Ther. 2003; 5, no. 2: 54–67

22 Bannuru RR, Natov NS, Obadan IE et al. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum. 2009; 61, no. 12: 1704–11

23 Colen S, van den Bekerom MPJ, Mulier M et al. Hyaluronic acid in the treatment of knee osteoarthritis: a systematic review and meta-analysis with emphasis on the efficacy of different products. BioDrugs 2012; 26: 257–68

24 Academy A, Board OS. Treatment of osteoarthritis of the knee evidence-based guideline, 2nd edition. Adopted by the American Academy of Orthopaedic Surgeons Board of Directors 2013

25 Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009; 27, no. 3: 158–67

26 Nurden AT, Nurden P, Sanchez M et al. Platelets and wound healing. Front. Biosci.2008; 13: 3532–48

27 Xie X, Zhang C, Tuan RS. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res. Ther. 2014; 16, no. 1: 204

28 Sánchez M, Fiz N, Azofra J et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy 2012; 28, no. 8: 1070–8

29 Sánchez M, Anitua E, Azofra J. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin. Exp. Rheumatol.; 26, no. 5: 910–3.

30 Spaková T, Rosocha J, Lacko M et al. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am. J. Phys. Med. Rehabil. 2012; 91, no. 5: 411–7

31 Laudy ABM, Bakker EWP, Rekers M et al. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br. J. Sports Med. 2014

32 Khoshbin A, Leroux T, Wasserstein D et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthroscopy 2013; 29, no. 12: 2037–48

33. Wang Y, Hall S, Hanna F et al. Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial. BMC Musculoskelet Disord. 2011; 12: 195

Fussnoten

1 St. Marien- und Annastiftskrankenhaus, Orthopädische und Unfallchirurgische Klinik, Ludwigshafen

SEITE: 1 | 2 | 3 | 4